FDA greenlights remdesivir as first and only fully-approved treatment for COVID-19
The Food and Drug Administration has given final approval to remdesivir as a treatment for COVID-19, making it the first and only fully-approved treatment in the U.S. for the novel coronavirus, CNBC reports. The drug has been permitted in cases of emergency use authorization since May, and was one of the medications used to treat President Trump when he was hospitalized earlier this month.
Remdesivir (sold under the brand name Veklury) is administered via an IV, and is intended for "the treatment of COVID-19 requiring hospitalization," the drugmaker, Gilead Sciences, said in a statement. While it is approved or authorized for temporary use in around 50 countries, a World Health Organization study earlier this month of some 2,750 patients found that remdesivir had "little or no effect" on death rates.
In a separate study by Gilead Sciences of 1,060 patients, the drug was found to prevent people from "getting sicker" and "from going onto more oxygen support," though the drugmaker likewise "did not find a statistically significant reduction in death rates across the entirety of patients treated in the trial," CNBC writes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
'Test of faith for Trump Media's investors'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Will Iran attack hinder support for Ukraine?
Today's Big Question Pro-Kyiv allies cry 'hypocrisy' and 'double standards' even as the US readies new support package
By Elliott Goat, The Week UK Published
-
How to find cheaper car insurance as premiums accelerate
The Explainer Car insurance costs are rising but there are ways to put the brakes on price rises
By Marc Shoffman, The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published